Biogen advances Alzheimer's drug to late-stage trial despite disappointing data
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen plans to advance an experimental drug for Alzheimer's disease to late-stage...
A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen plans to advance an experimental drug for Alzheimer's disease to late-stage...
Check out the companies making the biggest moves in premarket trading: Biogen — Shares advanced 4% after the biopharmaceutical company...
Pershing Square USA begins trading well below IPO pricePershing Square signage during the company's initial public offering (IPO) at the...
Check out the companies making the biggest moves premarket: McCormick — Shares rose more than 3% after Unilever confirmed it...
Check out the companies making headlines in midday trading. Biogen — The biotech's stock tumbled more than 4% after the...
Check out the companies making the biggest moves midday: Generac — The generator company gained 8% after Bank of America...